U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07664397) titled 'Imaging Study of [89Zr]DFO-YS5 for Cancer Detection' on June 17.
Brief Summary: This is a single-center, pilot, PET-imaging study of the novel radiotracer 89Zirconium-89 DFO conjugated to the YS5 monoclonal antibody ([89Zr]DFO-YS5) in participants with nerve sheath tumor, bladder cancer, or advanced solid tumor neoplasms.
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition:
Bladder Cancer
Nerve Sheath Tumor
Nerve Sheath Tumors
Solid Tumor Malignancies
Solid Tumor Cancer
Solid Tumor Neoplasms
Advanced Solid Tumor
Bladder Neoplasm
Nerve Sheath Neoplasms
Nerve Sheath Tumor, Nos
Solid Tumor, Adult
Solid Carcinoma
Interve...